201 related articles for article (PubMed ID: 32245249)
1. KLF5 Is Crucial for Androgen-AR Signaling to Transactivate Genes and Promote Cell Proliferation in Prostate Cancer Cells.
Li J; Zhang B; Liu M; Fu X; Ci X; A J; Fu C; Dong G; Wu R; Zhang Z; Fu L; Dong JT
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32245249
[TBL] [Abstract][Full Text] [Related]
2. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
3. Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.
Che M; Chaturvedi A; Munro SA; Pitzen SP; Ling A; Zhang W; Mentzer J; Ku SY; Puca L; Zhu Y; Bergman AM; Severson TM; Forster C; Liu Y; Hildebrand J; Daniel M; Wang TY; Selth LA; Hickey T; Zoubeidi A; Gleave M; Bareja R; Sboner A; Tilley W; Carroll JS; Tan W; Kohli M; Yang R; Hsieh AC; Murugan P; Zwart W; Beltran H; Huang RS; Dehm SM
Nat Commun; 2021 Nov; 12(1):6377. PubMed ID: 34737261
[TBL] [Abstract][Full Text] [Related]
4. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel androgen receptor target genes in prostate cancer.
Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
8. KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism.
Poluri RTK; Paquette V; Allain ÉP; Lafront C; Joly-Beauparlant C; Weidmann C; Droit A; Guillemette C; Pelletier M; Audet-Walsh É
Endocr Relat Cancer; 2021 Apr; 28(4):257-271. PubMed ID: 33690159
[TBL] [Abstract][Full Text] [Related]
9. Krüppel-like factor 5 promotes apoptosis triggered by tumor necrosis factor α in LNCaP prostate cancer cells via up-regulation of mitogen-activated protein kinase kinase 7.
Shi Q; Gao Y; Xu S; Du C; Li F; Tang XS; Jia J; Wang X; Chang L; He D; Guo P
Urol Oncol; 2016 Feb; 34(2):58.e11-8. PubMed ID: 26480897
[TBL] [Abstract][Full Text] [Related]
10. SMILE upregulated by metformin inhibits the function of androgen receptor in prostate cancer cells.
Lee SY; Song CH; Xie YB; Jung C; Choi HS; Lee K
Cancer Lett; 2014 Nov; 354(2):390-7. PubMed ID: 25199764
[TBL] [Abstract][Full Text] [Related]
11. Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells.
Karacosta LG; Kuroski LA; Hofmann WA; Azabdaftari G; Mastri M; Gocher AM; Dai S; Hoste AJ; Edelman AM
Prostate; 2016 Feb; 76(3):294-306. PubMed ID: 26552607
[TBL] [Abstract][Full Text] [Related]
12. Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells.
Li X; Zhang B; Wu Q; Ci X; Zhao R; Zhang Z; Xia S; Su D; Chen J; Ma G; Fu L; Dong JT
Int J Cancer; 2015 Feb; 136(3):536-46. PubMed ID: 24931571
[TBL] [Abstract][Full Text] [Related]
13. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
[TBL] [Abstract][Full Text] [Related]
15. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.
Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL
Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975
[TBL] [Abstract][Full Text] [Related]
16. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
17. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
18. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.
Levina E; Ji H; Chen M; Baig M; Oliver D; Ohouo P; Lim CU; Schools G; Carmack S; Ding Y; Broude EV; Roninson IB; Buttyan R; Shtutman M
Oncotarget; 2015 May; 6(15):13088-104. PubMed ID: 26036626
[TBL] [Abstract][Full Text] [Related]
20. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
